Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transformed mantle cell lymphoma with additional triple-hit genotypes can be resistant to a Bruton tyrosine kinase inhibitor.

Blood - 16 May 2024

Yuan Chang-Tsu, Ma Wei-Li

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Agammaglobulinaemia Tyrosine Kinase
Share to Drug Resistance, Neoplasm
Share to Genotype
Share to Lymphoma, Mantle-Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein Kinase Inhibitors

Share to Protein-Tyrosine Kinases

Share to Pyrimidines

Share to Tyrosine Kinase Inhibitors

Source

Identifiers

PMID: 38753358
DOI: 10.1182/blood.2024023818

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transformed mantle cell lymphoma with additional triple-hit genotypes can be resistant to a Bruton tyrosine kinase inhibitor.PMID 38753358Read ↗

Gene mutations and actionable genetic lesions in mantle cell lymphoma.Semantic proximity Read ↗

Pleural fluid overload-associated large B-cell lymphoma with a formerly double-hit genotype.Semantic proximity Read ↗

Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies.Semantic proximity Read ↗

Oncogenic MYD88 mutations are rare events in double-hit B-cell lymphomas.Semantic proximity Read ↗

Overcoming ibrutinib resistance by targeting phosphatidylinositol-3-kinase signaling in diffuse large B-cell lymphomaSemantic proximity Read ↗

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphomaSemantic proximity Read ↗

Resistance Mechanism for Zanubrutinib in Marginal Zone Lymphoma.Semantic proximity Read ↗

Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – a case reportSemantic proximity Read ↗

MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.Semantic proximity Read ↗

Resistance to Bruton Tyrosine Kinase Inhibitors.Semantic proximity Read ↗

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.Semantic proximity Read ↗

Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.